Amazon helps sellers procure oxygen concentrators for customers in India

"To address the growing customer demand and shortage of critical medical equipment, Amazon India is working with sellers on its marketplace to help them bring in about 9,000 oxygen concentrators for customers in India," it said.

PTI

May 16, 2021 / 17:27 IST

E-commerce major Amazon is working with sellers on its marketplace in India to help them procure about 9,000 oxygen concentrators for customers in the country.

The first batch of 1,000 oxygen concentrators have already landed in India, and are now available for purchase for consumers and business customers.

The rest are expected to come through in the second half of the month. Sellers on Amazon will now be offering oxygen concentrators along with other genuine and high-quality products like oxymeters, thermometers, masks, gloves, sanitizers and disinfectants for customers across India, Amazon India said in a blogpost.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

"To address the growing customer demand and shortage of critical medical equipment, Amazon India is working with sellers on its marketplace to help them bring in about 9,000 oxygen concentrators for customers in India," it said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show